adhesion and trans-endothelial migration were measured using fluorescence-based assays. Reactive oxygen species (ROS) production was measured using an enzymatic assay to assess hydrogen peroxide (H 2 O 2 ) generation. NETosis was measured using a novel capture ELISA. Bronchoalveolar lavage (BAL) were obtained from ILD or control patients and assessed for NETs. Results FMISO-PET scans indicated localised hypoxia in fibrotic regions in ILD patients. Hypoxia was also determined in lung sections, which demonstrated positive HIF-1a in ILD but not control lung sections. ILD-BAL had significantly greater levels of NETS compared to control (p=0.0039). Hypoxia did not affect b 1 integrin expression, however increased surface expression of the a M and aX subunits (p=0.0001 and 0.0179 respectively). Unstimulated, PMA-and LPS-stimulated neutrophil adhesion to both resting and activated endothelial monolayers were enhanced under hypoxia. Neutrophil trans-endothelial migration, across both resting and activated endothelial cells, was also greater in hypoxia (p<0.05). Interestingly, whilst ROS generation was not affected by hypoxia, both spontaneous and PMA-induced NETosis were increased under hypoxic conditions (p<0.05 and 0.001 respectively). Conclusions We have demonstrated that localised hypoxia is a feature of the ILD lung. Moreover, elevated NETs were found in ILD-BAL, suggesting a role for aberrant neutrophil activation in ILD pathology. Hypoxia increased neutrophil b 2 integrin expression, adhesion to endothelial monolayers, trans-endothelial migration and NETosis. Further work is underway to investigate the signalling pathways underlying neutrophil activation in ILD.
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Abstract S80 Table 1 Comparison of exercise performance, asthma control, health related quality of life, depression and anxiety and airway inflammation between AT-PR and UC. Data presented as mean (SD) for before and after intervention results and mean (95% CI) for changes between group. *significant difference at baseline between groups, # data presented as geometric mean (log SD 
